Pathogenicity of individual rhinovirus species during exacerbations of cystic fibrosis

Shah Amna, Connelly Michael, Whitaker Paul, McIntyre Chloe, Etherington Christine, Denton Miles, Hale Anthony, Harvala Heli, Simmonds Peter, Peckham Daniel G.

Source: Eur Respir J 2015; 45: 1748-1751
Journal Issue: June

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Shah Amna, Connelly Michael, Whitaker Paul, McIntyre Chloe, Etherington Christine, Denton Miles, Hale Anthony, Harvala Heli, Simmonds Peter, Peckham Daniel G.. Pathogenicity of individual rhinovirus species during exacerbations of cystic fibrosis. Eur Respir J 2015; 45: 1748-1751

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Frequency and pathogenicity of rhinovirus associated pulmonary exacerbations in patients with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013

Respiratory viruses in adults with cystic fibrosis during stable and exacerbations
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019

Viral infections trigger exacerbations of cystic fibrosis in adults and children
Source: Eur Respir J 2012; 40: 510-512
Year: 2012


Respiratory infections in cystic fibrosis
Source: ERS Courses: Paediatric respiratory infections
Year: 2019


Differential interferon response of the cystic fibrosis bronchial epithelium to major and minor group rhinovirus infection
Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment
Year: 2015

Sputum bacterial concentrations and exacerbations of non cystic fibrosis bronchiectasis
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008

Role of stenotrophomonas maltophilia infection in CF pulmonary exacerbations
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


Differences in clinical features and biomarkers of subsequent acute cystic fibrosis pulmonary exacerbations - Analysing exacerbations as separate entities
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013


Fosfomycin for pseudomonas related exacerbations of cystic fibrosis
Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools
Year: 2008


The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis
Source: Eur Respir Rev, 28 (152) 190045; 10.1183/16000617.0045-2019
Year: 2019



Bacterial infection and lung function in patients with cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 615s
Year: 2005

Evolution of the infectious disease in cystic fibrosis (CF)
Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases
Year: 2008


Cystic fibrosis patients have different microbiological colonization comparing to other bronchiectasis
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010

Emerging pathogens in cystic fibrosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=66
Year: 2006

Molecular detection of complex microbial communities in sputa of patients with cystic fibrosis and non cystic fibrosis bronchiectasis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010

Temperate bacteriophages of pseudomonas aeruginosa as markers of bacterial adaptation in CF and non-CF bronchiectasis
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014


Susceptibility of problem respiratory pathogens to levofloxacin in cystic fibrosis (CF)
Source: Eur Respir J 2002; 20: Suppl. 38, 526s
Year: 2002

Azithromycin in chronic respiratory infections with pseudomonas aeruginosa in patients without cystic fibrosis
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008


Assessing response to treatment of exacerbations of bronchiectasis in adults
Source: Eur Respir J 2009; 33: 312-318
Year: 2009



Non-ABPA Aspergillus bronchitis in cystic fibrosis
Source: International Congress 2017 – Cystic fibrosis: clinical issues
Year: 2017